HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study of erythrocyte delta-aminolevulinic acid dehydratase activity in porphyria cutanea tarda.

Abstract
The erythrocyte delta-aminolevulinic acid dehydratase activity was studied in porphyria cutanea tarda patients, compared to healthy controls, in an attempt to resolve the contradictions in the relevant literature data. In an in vitro experimental system, a study was also made of how the erythrocyte delta-aminolevulinic acid dehydratase activity varies on the action of the activators -SH and Zn2+. It was found that, compared to the healthy controls, the erythrocyte delta-aminolevulinic acid dehydratase activity of porphyria cutanea tarda patients is significantly decreased, but it is restored to the original activity level on the addition of -SH and Zn2+. Since there is a general -SH requirement of delta-aminolevulinic acid dehydratase, the most obvious explanation for the decrease of the activity in the case of the patients is the shift of the natural redox systems of the erythrocytes, and the decrease of the reduced glutathione/oxidized glutathione ratio.
AuthorsN Simon, M Kiss
JournalArchives of dermatological research (Arch Dermatol Res) Vol. 266 Issue 2 Pg. 121-6 (Oct 1979) ISSN: 0340-3696 [Print] Germany
PMID526041 (Publication Type: Journal Article)
Chemical References
  • Sulfhydryl Compounds
  • Porphobilinogen Synthase
  • Glutathione
  • Zinc
Topics
  • Adult
  • Aged
  • Erythrocytes (enzymology)
  • Female
  • Glutathione
  • Humans
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Porphobilinogen Synthase (analysis)
  • Porphyrias (enzymology)
  • Skin Diseases (enzymology)
  • Sulfhydryl Compounds (pharmacology)
  • Zinc (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: